Copertina

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Paola Rogliani, Clive Page, Francesco Facciolo, Mia Lundblad, Luigino Calzetta
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Role of protein kinase A and A kinase anchoring proteins in buffering and compartmentation of cAMP signalling in human airway smooth muscle cells
di: Rinzhin T. Sherpa, et al.
Pubblicazione: (2024)

P2Y14 receptor activation of platelets induces Ca2+ mobilization and Rho‐GTPase‐dependent motility that requires an interaction with P2Y1 receptors
di: Md Monir Hossain, et al.
Pubblicazione: (2025)

Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
di: Rolien Bosch, et al.
Pubblicazione: (2024)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
di: Jae‐Hun Ahn, et al.
Pubblicazione: (2025)

Clinically relevant niclosamide concentrations modulate TMEM16A and CaV1.2 channels to control artery tone and capillary diameter
di: Rachel Kaye, et al.
Pubblicazione: (2025)

Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription
di: Patrick G. Schweickert, et al.
Pubblicazione: (2025)

In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants
di: Charlotte Kölz, et al.
Pubblicazione: (2024)

Airway epithelial overexpressed cathepsin K induces airway remodelling through epithelial–mesenchymal trophic unit activation in asthma
di: Ling Qin, et al.
Pubblicazione: (2024)

Characterisation of neurogenic lipolytic responses in white adipose tissue ex vivo
di: Kayleigh E. Goddard, et al.
Pubblicazione: (2025)

Asthma and inflammation transcriptionally up‐regulate the aryl hydrocarbon receptor in airway smooth muscle via p38/JNK‐AP1 signalling
di: Mohammad Irshad Reza, et al.
Pubblicazione: (2025)

Development of a novel tyrosine kinase 2 inhibitor ARTS‐011 and its first‐in‐human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects
di: Zhili Jin, et al.
Pubblicazione: (2026)

Immunotherapy in cancer: novel approaches and future perspectives
di: Barbara Stefanska, et al.
Pubblicazione: (2025)

Psilocybin as a novel treatment for chronic pain
di: Tate Askey, et al.
Pubblicazione: (2024)

Single‐dose pharmacokinetics and safety of ACC017, a novel HIV integrase inhibitor, in healthy adult participants: A first‐in‐human study
di: C. Hu, et al.
Pubblicazione: (2025)

Amylin analogues as a novel perspective in anti‐obesity therapy
di: Thomas A. Lutz
Pubblicazione: (2026)

Natural products: Call for hard evidence
di: Francesco Visioli
Pubblicazione: (2024)

Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics
di: Bharath Srinivasan
Pubblicazione: (2025)

Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer
di: Éva Michaud, et al.
Pubblicazione: (2024)

A novel role for microtubule affinity‐regulating kinases in neuropathic pain
di: Yao‐Qin Shi, et al.
Pubblicazione: (2024)

Role of microtubule affinity‐regulating kinases in epilepsy: A novel therapeutic strategy
di: Min Xu, et al.
Pubblicazione: (2026)

Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator
di: Jiawei Zhang, et al.
Pubblicazione: (2024)

Endothelium‐ and epithelium‐derived novel endogenous catecholamines as modulators of the autonomic nervous system
di: Mariana G. de Oliveira, et al.
Pubblicazione: (2026)

Metabolic fate of drugs of abuse and new psychoactive substances: A pilot study on a novel workflow using a zebrafish embryo model combined with human microdosing
di: Simon K. Wellenberg, et al.
Pubblicazione: (2025)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
di: Dávid Nagy, et al.
Pubblicazione: (2025)

Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery
di: Ajeet Kumar, et al.
Pubblicazione: (2025)

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
di: Thi Viet Ha Nguyen, et al.
Pubblicazione: (2025)

Contribution of chloride channels to the action potential and contraction in human myometrium during labour
di: Helena C. Parkington, et al.
Pubblicazione: (2025)

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy
di: Elisa Kiselev, et al.
Pubblicazione: (2025)

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir
di: Mohamed Zamzamy, et al.
Pubblicazione: (2025)

Network medicine and systems pharmacology approaches to predicting adverse drug effects
di: Alessio Funari, et al.
Pubblicazione: (2024)

Higher sensitivity to ouabain‐induced toxicity in human induced pluripotent stem cell‐derived cardiomyocytes than human adult heart tissue despite similar Na + /K + ‐ATPase pump current amplitudes
di: Djemail Ismaili, et al.
Pubblicazione: (2026)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Pubblicazione: (2024)

Pharmacological profiling of small molecule modulators of the TMEM16A channel and their implications for the control of artery and capillary function
di: Rumaitha Al‐Hosni, et al.
Pubblicazione: (2025)

Identification of new small molecules for selective inhibition of SERCA 1 in patient‐derived metastatic papillary thyroid cancer
di: Seok‐Mo Kim, et al.
Pubblicazione: (2025)

Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes
di: Alberto Santiago‐Balmaseda, et al.
Pubblicazione: (2026)

Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors
di: Jessica L. Meades, et al.
Pubblicazione: (2025)

Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study
di: Emilia Hoste, et al.
Pubblicazione: (2025)

A novel reuptake inhibitor, IP2015, induces erection by increasing central dopamine and peripheral nitric oxide release
di: Simon Comerma‐Steffensen, et al.
Pubblicazione: (2024)

A novel marine‐derived mitophagy inducer ameliorates mitochondrial dysfunction and thermal hypersensitivity in paclitaxel‐induced peripheral neuropathy
di: Sangwoo Im, et al.
Pubblicazione: (2024)

Ibuprofen inhibits human sweet taste and glucose detection implicating an additional mechanism of metabolic disease risk reduction
di: Emily C. Hanselman, et al.
Pubblicazione: (2025)